Literature DB >> 8904413

Changing practices in mycobacteriology: a follow-up survey of state and territorial public health laboratories.

B R Bird1, M M Denniston, R E Huebner, R C Good.   

Abstract

The resurgence of tuberculosis, which includes an increase in the isolation of multidrug-resistant strains of Mycobacterium tuberculosis, emphasizes the need for more rapid laboratory testing for identification of the etiological agent of the disease. In December 1991, state and territorial public health laboratories were surveyed to determine the methods that they were using for testing and reporting of M. tuberculosis. A follow-up survey was conducted in June 1994 to measure changes in the testing and reporting practices that had occurred as a result of efforts focused on the disease and on laboratory improvement. Completed questionnaires were received from 51 of 55 laboratories. Comparative data indicate that the proportion of laboratories reporting testing results within the number of days recommended by the Centers for Disease Control and Prevention has increased. Starting from the time at which the laboratory receives the specimen, the proportion of laboratories reporting the results of microscopic smear examination within the recommended 24 h has increased from 52.1 to 77.6%; the proportion reporting isolation and identification within 21 days has increased from 22.1 to 72.9%; and the proportion reporting results of isolation, identification, and drug susceptibility testing within 28 days has increased from 16.7 to 48.9%. Use of the recommended rapid testing methods has also increased: the proportion of laboratories using fluorescence staining for acid-fast microscopy has increased from 71.4 to 85.7%, the proportion using BACTEC for primary culture has increased from 27.1 to 79.6%, the proportion using rapid methods for M. tuberculosis identification has increased from 74.5 to 100.0%, and the proportion using BACTEC for primary drug susceptibility testing has increased from 26.2 to 73.3%. By implementing the recommended methods for M. tuberculosis testing and reporting, state and territorial public health laboratories are now able to transmit results to physicians more rapidly.

Entities:  

Mesh:

Year:  1996        PMID: 8904413      PMCID: PMC228845          DOI: 10.1128/jcm.34.3.554-559.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  3 in total

1.  The resurgence of tuberculosis: is your laboratory ready?

Authors:  F C Tenover; J T Crawford; R E Huebner; L J Geiter; C R Horsburgh; R C Good
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

2.  Current practices in mycobacteriology: results of a survey of state public health laboratories.

Authors:  R E Huebner; R C Good; J I Tokars
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

Review 3.  The epidemiology of multidrug-resistant tuberculosis in the United States.

Authors:  J H Kent
Journal:  Med Clin North Am       Date:  1993-11       Impact factor: 5.456

  3 in total
  13 in total

1.  Use of recommended laboratory testing methods among patients with tuberculosis in California.

Authors:  S Kellam; L Pascopella; E Desmond; A Reingold; D P Chin
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Rapid detection of mycobacteria in clinical specimens by using the automated BACTEC 9000 MB system and comparison with radiometric and solid-culture systems.

Authors:  G E Pfyffer; C Cieslak; H M Welscher; P Kissling; S Rüsch-Gerdes
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  Rapid method for testing susceptibility of Mycobacterium tuberculosis by using DNA probes.

Authors:  N Martin-Casabona; D Xairó Mimó; T González; J Rossello; L Arcalis
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

4.  Turnaround times for mycobacterial cultures.

Authors:  B A Styrt; T M Shinnick; J C Ridderhof; J T Crawford; F C Tenover
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

5.  Trends in Testing for Mycobacterium tuberculosis Complex From US Public Health Laboratories, 2009-2013.

Authors:  Frances Tyrrell; Cortney Stafford; Mitchell Yakrus; Monica Youngblood; Andrew Hill; Stephanie Johnston
Journal:  Public Health Rep       Date:  2016-12-12       Impact factor: 2.792

6.  Descriptive profile of tuberculin skin testing programs and laboratory-acquired tuberculosis infections in public health laboratories.

Authors:  A S Kao; D A Ashford; M M McNeil; N G Warren; R C Good
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

7.  Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

Authors:  G P Morlock; J T Crawford; W R Butler; S E Brim; D Sikes; G H Mazurek; C L Woodley; R C Cooksey
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

8.  Performance of an automated Q-beta replicase amplification assay for Mycobacterium tuberculosis in a clinical trial.

Authors:  J H Smith; G Radcliffe; S Rigby; D Mahan; D J Lane; J D Klinger
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

9.  Genetic and phenotypic characterizations of drug-resistant Mycobacterium tuberculosis isolates in Cheonan, Korea.

Authors:  Jae-Sik Jeon; Jae Kyung Kim; Qute Choi; Jong Wan Kim
Journal:  J Clin Lab Anal       Date:  2018-02-03       Impact factor: 2.352

10.  Laboratory reporting of tuberculosis test results and patient treatment initiation in California.

Authors:  Lisa Pascopella; Steffi Kellam; John Ridderhof; Daniel P Chin; Arthur Reingold; Edward Desmond; Jennifer Flood; Sarah Royce
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.